Evidence map›Paper›PMID 22157586›Full record

ArticleJournal of hypertension2012

Essential hypertension: perspectives and future directions.

Songcang Chen

Abstract readEditorialComment
In one paragraph

Article in Journal of hypertension, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Vitamin D and hypertension: Is there any significant relation?Chronic diseases and translational medicine · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Vitamin D deficiency and essential hypertension.Journal of the American Society of Hypertension : JASH · 2015
    Review
  11. Review
  12. Understanding hypertension in the light of Ayurveda.Journal of Ayurveda and integrative medicine
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Songcang Chen

Funding

A Role for Non-Hypercalcemic VDR Agonists in the Control of VSMC ProliferationR21HL096047 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, SONGCANG · 2010 to 2011
$425k
NHLBI NIH HHS HL096047NHLBI NIH HHS R21 HL096047
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Predisposition to DiseaseAnimalsHumansHypertension

Identifiers

PMID22157586
PMCPMC4152852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.